Form 8-K - Current report:
SEC Accession No. 0001828185-25-000004
Filing Date
2025-01-10
Accepted
2025-01-10 08:02:06
Documents
46
Period of Report
2025-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brns-20250110.htm   iXBRL 8-K 37072
2 EX-99.1 brns-20250110xexx991.htm EX-99.1 22833
3 EX-99.2 brns-20250110xexx992.htm EX-99.2 36893
8 a1.jpg GRAPHIC 5260
9 brns-20250110xexx992001.jpg GRAPHIC 78313
10 brns-20250110xexx992002.jpg GRAPHIC 229387
11 brns-20250110xexx992003.jpg GRAPHIC 56858
12 brns-20250110xexx992004.jpg GRAPHIC 123862
13 brns-20250110xexx992005.jpg GRAPHIC 128385
14 brns-20250110xexx992006.jpg GRAPHIC 109817
15 brns-20250110xexx992007.jpg GRAPHIC 140444
16 brns-20250110xexx992008.jpg GRAPHIC 82352
17 brns-20250110xexx992009.jpg GRAPHIC 55274
18 brns-20250110xexx992010.jpg GRAPHIC 115502
19 brns-20250110xexx992011.jpg GRAPHIC 116262
20 brns-20250110xexx992012.jpg GRAPHIC 117918
21 brns-20250110xexx992013.jpg GRAPHIC 120753
22 brns-20250110xexx992014.jpg GRAPHIC 136927
23 brns-20250110xexx992015.jpg GRAPHIC 125653
24 brns-20250110xexx992016.jpg GRAPHIC 62855
25 brns-20250110xexx992017.jpg GRAPHIC 99274
26 brns-20250110xexx992018.jpg GRAPHIC 55012
27 brns-20250110xexx992019.jpg GRAPHIC 94805
28 brns-20250110xexx992020.jpg GRAPHIC 131314
29 brns-20250110xexx992021.jpg GRAPHIC 138350
30 brns-20250110xexx992022.jpg GRAPHIC 143556
31 brns-20250110xexx992023.jpg GRAPHIC 123435
32 brns-20250110xexx992024.jpg GRAPHIC 144392
33 brns-20250110xexx992025.jpg GRAPHIC 146157
34 brns-20250110xexx992026.jpg GRAPHIC 152602
35 brns-20250110xexx992027.jpg GRAPHIC 53587
36 brns-20250110xexx992028.jpg GRAPHIC 96276
37 brns-20250110xexx992029.jpg GRAPHIC 58521
  Complete submission text file 0001828185-25-000004.txt   4767271

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brns-20250110.xsd EX-101.SCH 2640
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brns-20250110_def.xml EX-101.DEF 16922
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brns-20250110_lab.xml EX-101.LAB 29996
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brns-20250110_pre.xml EX-101.PRE 17774
49 EXTRACTED XBRL INSTANCE DOCUMENT brns-20250110_htm.xml XML 4246
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 25520512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)